Original Article
Copyright ©2012 Baishideng.
World J Gastrointest Oncol. Aug 15, 2012; 4(8): 193-201
Published online Aug 15, 2012. doi: 10.4251/wjgo.v4.i8.193
Table 1 Characteristics of cases and controls n (%)
Controls (n = 219)Cases (n = 221)P1
Age of randomization (mean) (yr)58 (54-62)58 (54-61)0.7
ATBC0.33
Placebo62 (28)48 (22)
Β-carotene56 (26)60 (27)
VitE49 (22)62 (28)
Both52 (24)51 (23)
Family history of CRC6 (3)6 (3)0.98
Smoking age (mean) (yr)20 (17-22)19 (17-20)0.18
Smoking years (mean) (yr)36 (30-42)37 (31-42)0.26
BMI (kg/m2)0.03
< 2580 (36)75 (34)
25-29.9113 (52)99 (45)
≥ 3026 (12)47 (21)
Table 2 Methylation of CpG sites associated with colorectal cancer development (P value < 0.01 before multiple testing correction)1
Marker name2nd tertile vs 1st tertile
3rd tertile vs 1st tertile
P2
ORL95U95ORL95U95
DSP1.098760.957721.260571.265391.117341.433060.000599826
MLH31.043490.906381.201341.266061.09941.457980.000731318
FLT41.259521.106311.433941.145130.989891.324730.00096231
INSR1.162361.019621.325091.240111.093171.406810.001490452
GLA1.370491.156651.623881.446121.194521.750720.001636963
PTCH21.180221.034751.346151.263741.114171.433390.001637435
GSTM21.243211.096561.409471.170841.026741.335160.001994473
HCK1.185731.044091.346591.196911.031991.388190.002287131
PLAGL10.916190.803631.044510.876450.757451.014140.002326078
PARP11.070160.951.205530.866630.755350.99430.003005978
COL18A11.239871.089011.411621.200141.053511.367190.003163099
KCNK41.194981.052731.356451.150651.007851.313680.003250103
GJB21.166051.028311.322241.027850.898771.175470.003317356
SEMA3F1.167031.017531.338481.164561.014561.336730.00380004
HBII0.897090.791211.017130.869690.76240.992070.004064919
SEMA3C1.087730.963831.227560.875970.769190.997570.004352617
MME_1.184261.041941.346011.171871.029591.33380.005258668
WNT1_1.185751.028071.367611.071020.910351.260040.005648004
SGCE1.07120.936711.225011.228321.081441.395160.00629186
PDE1B_1.242571.091821.414131.213841.046231.408310.008629968
HIC11.163481.011241.338641.224831.067651.405150.008997589
PODXL1.160341.021431.318151.124560.986751.28160.009182736
IL18BP1.177371.02541.351881.072990.914411.259080.009206805
DKC11.058220.920461.21661.228861.054631.431870.009315729
B3GALT50.951370.836211.082391.203651.058041.36930.009772808
SNRPN0.854410.75140.971550.981150.867791.10930.00995797
Table 3 Methylation of CpG sites related to colorectal cancer development with different latencies (P value < 0.01 before multiple testing correction)1
Marker name2nd tertile vs 1st tertile
3rd tertile vs 1st tertile
P2
ORL95U95ORL95U95
DSP1.520270.910542.538312.624231.651054.171030.000104474
PTCH21.865651.149463.028072.558511.601144.088320.000327688
GLA3.228961.660546.278793.623451.706277.694780.000529374
FLT42.498821.550514.027131.73121.029582.910950.000651567
B3GALT50.917350.57461.464542.111281.317093.384340.000726807
INSR1.889771.162813.071222.443711.527133.910430.0007899
GSTM22.294641.449033.633731.921031.180113.127120.001165928
FASTK1.661171.024572.693312.269991.433133.595530.001992703
MLH31.120630.675031.860362.151871.310983.532130.002175877
HOXC61.21890.757951.960152.068611.320563.240430.002826542
MGMT2.427471.341144.393732.715991.450275.086380.00448402
SYBL11.356610.894462.057540.639270.399711.022390.004618893
PDE1B2.122031.339593.361511.746631.017042.99960.004839975
SEMA3C1.340450.879152.043780.621260.385661.00080.004858838
AFF32.114731.307733.419731.881471.165883.036280.005422481
HCK2.04061.277663.259112.03381.194163.463820.005503
PXN1.921221.244212.96661.124930.668241.893740.005766585
PARP11.197080.792091.809130.550560.331910.913230.006004429
TK11.831721.075123.120752.247921.340643.769220.006184503
SGCE1.212170.746191.969161.96851.252573.093630.006354949
MME2.008581.254233.216631.940421.203083.129670.00664085
RARA1.515260.944052.432092.076391.316353.275250.006899358
COL18A12.086471.288933.377521.903161.179263.071440.007110996
SEMA3F1.985881.217153.240142.039761.226723.391660.007292652
ITGB42.086851.26693.437482.029191.202233.424950.007595246
PTPRH0.479220.300820.763430.719090.448231.153610.007598903
SMO1.521880.952762.430942.086041.30323.339150.008280298
DKC11.253260.763832.056322.203931.277853.801160.008427231
TRPM52.229621.332453.730871.806041.013893.217070.008971559
EVI11.628291.014152.614312.083731.296383.349270.009481166
EPHA31.932521.215763.071851.858271.158142.981650.009792546
Table 4 Methylation of CpG sites associated with colorectal cancer with short to mediate latency (P value < 0.01 before multiple testing correction)1
Marker name2nd tertile vs 1st tertile
3rd tertile vs 1st tertile
P2
ORL95U95ORL95U95
GLA1.316181.123031.542561.310821.090721.575340.000126734
DSP1.124060.98681.28041.251151.111461.40840.000305565
B3GALT51.001090.886641.13031.189311.050661.346250.001334159
MLH31.017190.891781.160251.24041.089161.412630.001421327
PTCH21.180441.043871.334871.242091.10261.399220.002140961
FLT41.260381.11591.423561.155181.011531.319240.002164413
SGCE1.051490.926781.192991.191261.057861.341480.002535873
HOXC61.023030.904261.157411.162531.033421.307770.002602644
PDE1B1.198451.063851.350091.105840.960461.273230.002706305
COL18A11.21261.071421.372391.199611.060581.356870.002968143
TRPM51.169511.023241.33671.101730.948791.279330.003084609
EVI11.061790.939671.199790.945120.82741.079590.003902443
GSTM21.240091.103121.394071.139521.00591.290890.003956314
FASTK1.127630.995131.277781.175391.043181.324360.004798386
PARP11.084750.970531.21240.879070.771191.002030.005028903
PTGS21.030080.911451.164151.153191.025741.296480.00571389
WRN0.978390.86141.111281.098670.966291.249180.005779497
EPO1.147311.013341.2991.130340.98541.29660.006090622
GPC31.190561.039811.363161.096980.943411.275560.006093671
TK11.134580.988461.302321.208621.057531.38130.006272625
EVI11.148821.015591.299531.178511.041421.333640.006474115
EPHB21.155961.028751.29891.052330.927011.194590.006504075
SEMA3C1.101970.984271.233750.895790.79211.013040.00677389
HLA_DPA11.146641.009651.302231.093260.959711.245380.006960326
SYBL11.068350.95471.195530.906350.802261.023940.007029222
INSR1.190211.052141.346391.254741.113321.414120.008045993